
Tigabu Kassa
Examiner (ID: 2231, Phone: (571)270-5867 , Office: P/1619 )
| Most Active Art Unit | 1619 |
| Art Unit(s) | 1619, 4161 |
| Total Applications | 904 |
| Issued Applications | 273 |
| Pending Applications | 138 |
| Abandoned Applications | 524 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18093375
[patent_doc_number] => 20220411716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => Consumer Products with Improved Aesthetics
[patent_app_type] => utility
[patent_app_number] => 17/340132
[patent_app_country] => US
[patent_app_date] => 2021-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17340132
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/340132 | Consumer Products with Improved Aesthetics | Jun 6, 2021 | Pending |
Array
(
[id] => 18056242
[patent_doc_number] => 20220387328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => DOSAGE FORM FOR NICOTINE REPLACEMENT THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/338747
[patent_app_country] => US
[patent_app_date] => 2021-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11438
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17338747
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/338747 | DOSAGE FORM FOR NICOTINE REPLACEMENT THERAPY | Jun 3, 2021 | Pending |
Array
(
[id] => 17312833
[patent_doc_number] => 20210401881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => RADIATION/CHEMOTHERAPY SENSITIZER TO BE USED FOR INTRATUMORAL LOCAL INJECTION AND FOR CONTROLLED RELEASE OF HYDROGEN PEROXIDE WITH HYDROGEL AS CARRIER
[patent_app_type] => utility
[patent_app_number] => 17/328865
[patent_app_country] => US
[patent_app_date] => 2021-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11302
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17328865
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/328865 | Radiation/chemotherapy sensitizer to be used for intratumoral local injection and for controlled release of hydrogen peroxide with hydrogel as carrier | May 23, 2021 | Issued |
Array
(
[id] => 18434181
[patent_doc_number] => 20230181475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => COMPOSITION COMPRISING METHYLFOLATE
[patent_app_type] => utility
[patent_app_number] => 17/998534
[patent_app_country] => US
[patent_app_date] => 2021-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11727
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998534
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/998534 | COMPOSITION COMPRISING METHYLFOLATE | May 9, 2021 | Pending |
Array
(
[id] => 18374235
[patent_doc_number] => 20230149312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => MODIFIED RELEASE PHARMACEUTICAL FORMULATION COMPRISING HYDROXYPROPYL CELLULOSE
[patent_app_type] => utility
[patent_app_number] => 17/920690
[patent_app_country] => US
[patent_app_date] => 2021-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17920690
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/920690 | MODIFIED RELEASE PHARMACEUTICAL FORMULATION COMPRISING HYDROXYPROPYL CELLULOSE | Apr 27, 2021 | Pending |
Array
(
[id] => 16990357
[patent_doc_number] => 20210228777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => METHODS FOR APPLYING A BIOACTIVE COATING ONTO A SURFACE OF AN IMPLANT
[patent_app_type] => utility
[patent_app_number] => 17/230063
[patent_app_country] => US
[patent_app_date] => 2021-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4851
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17230063
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/230063 | METHODS FOR APPLYING A BIOACTIVE COATING ONTO A SURFACE OF AN IMPLANT | Apr 13, 2021 | Abandoned |
Array
(
[id] => 18842509
[patent_doc_number] => 20230404913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => PHARMACEUTICAL FORMULATIONS FOR TREATING DISEASES ASSOCIATED WITH VOLTAGE-GATED SODIUM CHANNELS
[patent_app_type] => utility
[patent_app_number] => 18/248661
[patent_app_country] => US
[patent_app_date] => 2021-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11637
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18248661
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/248661 | PHARMACEUTICAL FORMULATIONS FOR TREATING DISEASES ASSOCIATED WITH VOLTAGE-GATED SODIUM CHANNELS | Apr 8, 2021 | Abandoned |
Array
(
[id] => 18420185
[patent_doc_number] => 20230174646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => Compositions and Methods For Blood-Brain Barrier Delivery
[patent_app_type] => utility
[patent_app_number] => 17/995768
[patent_app_country] => US
[patent_app_date] => 2021-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35390
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995768
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995768 | Compositions and Methods For Blood-Brain Barrier Delivery | Apr 6, 2021 | Pending |
Array
(
[id] => 16976015
[patent_doc_number] => 20210220252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => SILICONE-IN-WATER COSMETIC
[patent_app_type] => utility
[patent_app_number] => 17/224650
[patent_app_country] => US
[patent_app_date] => 2021-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4245
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17224650
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/224650 | SILICONE-IN-WATER COSMETIC | Apr 6, 2021 | Pending |
Array
(
[id] => 17065899
[patent_doc_number] => 20210268114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => TOPICAL FORMULATIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/200454
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30068
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17200454
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/200454 | Topical formulations comprising polyoxyl lipid or fatty acid and polyalkoxylated alcohol, and uses thereof | Mar 11, 2021 | Issued |
Array
(
[id] => 18374237
[patent_doc_number] => 20230149314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => ORAL COMPLEX TABLET COMPRISING SITAGLIPTIN, DAPAGLIFLOZIN, AND METFORMIN
[patent_app_type] => utility
[patent_app_number] => 17/915826
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6465
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915826
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/915826 | ORAL COMPLEX TABLET COMPRISING SITAGLIPTIN, DAPAGLIFLOZIN, AND METFORMIN | Mar 11, 2021 | Pending |
Array
(
[id] => 18278690
[patent_doc_number] => 20230094162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => CD137 BINDING MOLECULES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/798285
[patent_app_country] => US
[patent_app_date] => 2021-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47712
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17798285
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/798285 | CD137 binding molecules and uses thereof | Feb 15, 2021 | Issued |
Array
(
[id] => 18238863
[patent_doc_number] => 20230071174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => DICLOFENAC SODIUM-CONTAINING ADHESIVE PATCH
[patent_app_type] => utility
[patent_app_number] => 17/796365
[patent_app_country] => US
[patent_app_date] => 2021-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5852
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17796365
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/796365 | DICLOFENAC SODIUM-CONTAINING ADHESIVE PATCH | Feb 8, 2021 | Pending |
Array
(
[id] => 17020978
[patent_doc_number] => 20210244849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => L-PRF MESH REPAIR FOR INGUINAL HERNIA
[patent_app_type] => utility
[patent_app_number] => 17/169992
[patent_app_country] => US
[patent_app_date] => 2021-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8560
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17169992
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/169992 | L-PRF MESH REPAIR FOR INGUINAL HERNIA | Feb 7, 2021 | Abandoned |
Array
(
[id] => 18272328
[patent_doc_number] => 20230093570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => SOLID PREPARATION
[patent_app_type] => utility
[patent_app_number] => 17/801440
[patent_app_country] => US
[patent_app_date] => 2021-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11036
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17801440
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/801440 | SOLID PREPARATION | Feb 4, 2021 | Abandoned |
Array
(
[id] => 18243892
[patent_doc_number] => 20230076203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => DEVICE FOR THE DELIVERY OF A LIQUID PHARMACEUTICAL AND/OR NUTRACEUTICAL GELATIN SPECIALITY TO PERSONS HAVING DIFFICULTY IN SWALLOWING
[patent_app_type] => utility
[patent_app_number] => 17/760158
[patent_app_country] => US
[patent_app_date] => 2021-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2355
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17760158
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/760158 | DEVICE FOR THE DELIVERY OF A LIQUID PHARMACEUTICAL AND/OR NUTRACEUTICAL GELATIN SPECIALITY TO PERSONS HAVING DIFFICULTY IN SWALLOWING | Jan 27, 2021 | Pending |
Array
(
[id] => 18224106
[patent_doc_number] => 20230063100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => VETERINARY ANTI-PROLACTIN COMPOSITION FOR RUMINANTS USED BY INTRAMAMMARY ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 17/793324
[patent_app_country] => US
[patent_app_date] => 2021-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4992
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17793324
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/793324 | VETERINARY ANTI-PROLACTIN COMPOSITION FOR RUMINANTS USED BY INTRAMAMMARY ADMINISTRATION | Jan 25, 2021 | Pending |
Array
(
[id] => 19152370
[patent_doc_number] => 11977280
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-07
[patent_title] => Systems and methods for printing on a contact lens
[patent_app_type] => utility
[patent_app_number] => 17/159025
[patent_app_country] => US
[patent_app_date] => 2021-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 26
[patent_no_of_words] => 6235
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17159025
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/159025 | Systems and methods for printing on a contact lens | Jan 25, 2021 | Issued |
Array
(
[id] => 16839432
[patent_doc_number] => 20210147444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => POLYMORPHIC MIXTURE OF RIFAXIMIN AND ITS USE FOR THE PREPARATION OF SOLID FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/158843
[patent_app_country] => US
[patent_app_date] => 2021-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4830
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17158843
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/158843 | Polymorphic mixture of Rifaximin and its use for the preparation of solid formulations | Jan 25, 2021 | Issued |
Array
(
[id] => 16839432
[patent_doc_number] => 20210147444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => POLYMORPHIC MIXTURE OF RIFAXIMIN AND ITS USE FOR THE PREPARATION OF SOLID FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/158843
[patent_app_country] => US
[patent_app_date] => 2021-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4830
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17158843
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/158843 | Polymorphic mixture of Rifaximin and its use for the preparation of solid formulations | Jan 25, 2021 | Issued |